Post-earnings recap
Reported
Thu, Feb 20, 2025
EPS actual
$-0.62
EPS est.
$-0.74
EPS surprise
+15.76%
1-day move
-3.27%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Guardant Health's earnings report showed a narrower-than-expected loss per share, which was a positive surprise. However, the lack of revenue data and no guidance updates contributed to a negative stock reaction, with shares falling 3.27%. Investors may be concerned about the company's growth trajectory without clearer financial guidance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.62 | N/A | +15.76% |
| Revenue | N/A | N/A | N/A |
Management expressed a cautious optimism about future growth opportunities. They highlighted their commitment to innovation and market expansion.
Management emphasized the importance of ongoing investments in R&D.
They noted a focus on expanding their market presence despite current challenges.